article thumbnail

A Brief Mindfulness Intervention to Lower Repeat BP in Primary Care [Hypertension]

Annals of Family Medicine

Longer-duration interventions have demonstrated reduction of physiological parameters such as systolic blood pressure (Carlton 2007; Loucks 2019; Lee 2020). Blood pressure control is a major quality KPI impacting reimbursement from insurers for primary care practices.

article thumbnail

MN Legislative Session 2025: Updates on Health Care Bills

Minnesota Academy of Family Physicians

Committees reviewed a range of legislation, including efforts to address workforce shortages, expand insurance coverage and improve school health services. HOUSE HEALTH COMMITTEE On Wednesday, March 19, 2025, the House Health Committee heard a series of health care bills addressing insurance coverage and medication pricing.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Risking It All For a New Business Model at Family Physicians of St. Joe

Family Physicians of St. Joseph

Joseph, the family medicine practice is committed to providing exceptional, affordable, patient-centered primary care in SW Michigan without reliance on insurance companies for payment of services. In 2007, Dr. Mancini joined the practice, followed by Dr. Meadows in 2012, and Dr. Gendernalik in 2015. Family Physicians of St.

article thumbnail

4th Circuit En Banc Judgment Affirms District Court Decision in Best Price Stacking Case

FDA Law

The 4th Circuit three-judge panel decision relied heavily on the Supreme Court’s decision in Safeco Insurance Co. 47 (2007), which addressed the intent standard under the Fair Credit Reporting Act. of America v. Burr , 551 U.S.

article thumbnail

Ding Dong is the Skinny Label (Effectively) Dead?

FDA Law

Teva received tentative approval in June 2003 and launched in 2007 after a blocking patent expired. Amarin even sued a health insurer alleging active encouragement to use Hikma’s generic version instead of Vascepa for the patented indication. Par also has filed similar litigation.

IT 52
article thumbnail

Court Strikes Down CMS’s Accumulator Adjustment Rule That Threatened Manufacturer Patient Savings Programs

FDA Law

Since 2007, the best price regulation has contained exclusions for patient saving programs so long as the savings are passed on to the consumer, and do not represent a price concession to the pharmacy or other entity involved in the redemption or administration. See 42 C.F.R. §§ 447.505(c)(8)-(12).